Search

everythinglearnresearchcommunity

for

Search:↓

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Dupilumab for eczema may cause hair loss.

Bimekizumab effectively treated a man's chronic beard hair loss.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

New treatments for lupus show promise, but more research is needed, especially for children.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

A patient's grey hair regained color during treatment with adalimumab.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.